Published in Neoplasma on January 01, 2004
Tea and cancer prevention: epidemiological studies. Pharmacol Res (2011) 1.27
Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS. Bioanalysis (2011) 0.97
Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Does smoking influence the physical activity and lung cancer relation? A systematic review and meta-analysis. Eur J Epidemiol (2016) 0.87
A comparison of smokers' and nonsmokers' fruit and vegetable intake and relevant psychosocial factors. Behav Med (2009) 0.87
Red and processed meat consumption and the risk of lung cancer: a dose-response meta-analysis of 33 published studies. Int J Clin Exp Med (2014) 0.81
Dairy Product, Calcium Intake and Lung Cancer Risk: A Systematic Review with Meta-Analysis. Sci Rep (2016) 0.76
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL). Ann Oncol (2010) 3.40
Estimating lung cancer mortality from residential radon using data for low exposures of miners. Radiat Res (1997) 2.08
Third consensus on medical treatment of metastatic breast cancer. Ann Oncol (2009) 1.96
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Ann Oncol (2011) 1.88
Patterns of cigarette sales and lung cancer mortality in some central and eastern European countries, 1960-1989. Cancer (1995) 1.86
Childhood leukaemia following the Chernobyl accident: the European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS). Eur J Cancer (1992) 1.81
Studies of radon-exposed miner cohorts using a biologically based model: comparison of current Czech and French data with historic data from China and Colorado. Radiat Environ Biophys (2004) 1.79
Cancer in man after exposure to Rn daughters. Health Phys (1988) 1.51
Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst (1995) 1.51
Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer (2000) 1.44
Evaluation of methods for differentiating pathogenic and saprophytic leptospira strains. Ann Soc Belges Med Trop Parasitol Mycol (1966) 1.40
Second consensus on medical treatment of metastatic breast cancer. Ann Oncol (2006) 1.37
European health systems and cancer care. Ann Oncol (2003) 1.27
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer. Ann Oncol (2008) 1.13
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial. Br J Cancer (2006) 1.07
Parity and cancer risk in Slovakia. Int J Cancer (1985) 1.07
Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. Dis Esophagus (2009) 1.05
Disseminated Nocardia asteroides infection in an immunocompetent woman following an arm injury. Infection (2003) 1.02
Dietary habits and lung cancer risk among non-smoking women. Eur J Cancer Prev (2004) 0.98
Intertype immunity relations of Leptospira strains belonging to the "Australis" serogroup. Biologia (Bratisl) (1970) 0.92
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients. Ann Oncol (2001) 0.89
A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma (2008) 0.89
Randomized, double-blind, multicenter trial comparing two doses of arzoxifene (LY353381) in hormone-sensitive advanced or metastatic breast cancer patients. Ann Oncol (2003) 0.89
Criteria of postvaccinal immunity in leptospirosis. Ann Soc Belges Med Trop Parasitol Mycol (1966) 0.87
Activity of fulvestrant in HER2-overexpressing advanced breast cancer. Ann Oncol (2009) 0.87
Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors. J BUON (2012) 0.85
Transition in yield and azimuthal shape modification in dihadron correlations in relativistic heavy ion collisions. Phys Rev Lett (2010) 0.85
Carbonyl and oxidative stress in patients with breast cancer--is there a relation to the stage of the disease? Neoplasma (2007) 0.84
Dosimetric calculations for uranium miners for epidemiological studies. Radiat Prot Dosimetry (2011) 0.84
Large expansion of morphologically heterogeneous mammary epithelial cells, including the luminal phenotype, from human breast tumours. Breast Cancer Res Treat (2002) 0.83
A case-control study of lung cancer among Czech women. Lung Cancer (2001) 0.83
[Meningeal carcinomatosis as the first manifestation of gastric adenocarcinoma]. Cas Lek Cesk (2001) 0.83
Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study. Ann Oncol (2004) 0.82
Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer (2006) 0.82
Bronchial carcinoid tumors: long-term outcome after surgery. Neoplasma (2003) 0.82
Survival of children with thyroid cancer in Europe 1978--1989. Eur J Cancer (2001) 0.81
Human exposure to polyhalogenated hydrocarbons and incidence of selected malignancies -central European experience. Neoplasma (2009) 0.81
[Cross immunity in experimental leptospirosis. Reciprocal protective effects effected by Grippotyphosa strains and strains of other serogroups]. Ann Inst Pasteur (Paris) (1970) 0.80
Diet and the risk of lung cancer among women. A hospital-based case-control study. Neoplasma (2001) 0.80
Prediction of lung cancer mortality in four Central European countries, 1990-2009. Neoplasma (1998) 0.80
Gemcitabine in non-small cell lung cancer (NSCLC). Invest New Drugs (2000) 0.79
System size and energy dependence of jet-induced hadron pair correlation shapes in Cu+Cu and Au+Au collisions at square root sNN=200 and 62.4 GeV. Phys Rev Lett (2007) 0.79
Prognostic significance of c-erbB-2 gene expression in pancreatic cancer patients. Neoplasma (2001) 0.79
Interactions between smoking and other exposures associated with lung cancer risk in women: diet and physical activity. Neoplasma (2007) 0.79
[Incidence of thyroid cancer in Slovakia: extensive evidence from one centre in the context of national data]. Cas Lek Cesk (2007) 0.79
Improving survival for childhood cancer in Slovakia. Int J Cancer (1996) 0.78
Lessons from the ("Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations. Br J Cancer (2003) 0.78
Mammaglobin A, a novel marker of minimal residual disease in early stages breast cancer. Neoplasma (2004) 0.78
Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue. Neoplasma (2005) 0.78
Larynx cancer in Slovakia and the role of anatomical subsites. Oral Oncol (1999) 0.78
Recent trends in uterine cervix cancer in Slovakia, 1968-1987. Neoplasma (1991) 0.77
Influence of chemotherapy to hormonal levels in postmenopausal breast cancer patients. Neoplasma (2008) 0.77
Predictive factors for the presence of tumor cells in bone marrow and peripheral blood in breast cancer patients. Neoplasma (2015) 0.77
Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the Czech Republic. Med Princ Pract (2003) 0.77
Clinical correlations of potential activity markers in systemic sclerosis. Ann N Y Acad Sci (2005) 0.77
Suppression pattern of neutral pions at high transverse momentum in Au + Au collisions at sqrt[sNN]=200 GeV and constraints on medium transport coefficients. Phys Rev Lett (2008) 0.77
Trefoil factor family (TFF) proteins as potential serum biomarkers in patients with metastatic colorectal cancer. Neoplasma (2015) 0.77
Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II study. Lung Cancer (1998) 0.76
Management of inoperable carcinoma of the breast by curative radiotherapy and chemo-hormonotherapy. Onkologie (2001) 0.76
Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience. Neoplasma (2016) 0.76
Measurement of high-pT single electrons from heavy-flavor decays in p + p collisions at square root of s = 200 GeV. Phys Rev Lett (2006) 0.76
Epidemiological features of gastric and oesophageal cancers in Slovakia. Br J Cancer (1994) 0.76
[The NanoKnife and two successful cases of intracavitary irreversible electroporation of main bronchus tumours]. Rozhl Chir (2012) 0.75
Measurement of bottom versus charm as a function of transverse momentum with electron-hadron correlations in p + p collisions at square root of s = 200 GeV. Phys Rev Lett (2009) 0.75
Enhanced production of direct photons in Au + Au collisions at square root(S(NN)) = 200 GeV and implications for the initial temperature. Phys Rev Lett (2010) 0.75
[A comparison of the effectiveness of 3 therapeutic preventive programs for neurotics. IV. Risk index for an unfavorable prognosis of the neurosis. Report on Program P 17]. Cesk Psychiatr (1983) 0.75
Analysis of the time series of the EEG frequency spectra and of EEG spectral power densities. Act Nerv Super (Praha) (1981) 0.75
[Five-year follow-up of the prague sample of mental patients. I. Design, methods. A report from the WHO International Pilot Study of Schizophrenia]. Cesk Psychiatr (1982) 0.75
Computer-assisted analysis of human G-banded chromosomes. Comput Biomed Res (1983) 0.75
Epidemiologic aspects of malignant skin melanoma in Slovakia. Neoplasma (1985) 0.75
Predicting axillary sentinel node status in patients with primary breast cancer. Neoplasma (2013) 0.75
[Treatment of colorectal liver metastases: a current view]. Klin Onkol (2010) 0.75
[Comparison of the effectiveness of three therapeutic programmes in neurosis. I. Design, methods. Report from P 17 SPTR (author's transl)]. Cesk Psychiatr (1981) 0.75
[Comparison of 3 therapeutic programs for neurotics. III. Results of factor analysis. Report from the P17 SPTR program]. Cesk Psychiatr (1983) 0.75
Epidemiological features of biliary tract cancer incidence in Slovakia. Neoplasma (1985) 0.75
[Prognostication of trends in the mortality of malignant tumors in Czechoslovakia]. Cesk Zdrav (1984) 0.75
[5-year follow-up of the Prague group of mentally ill patients. II. Results. Report from the WHO International Research Study on Schizophrenia]. Cesk Psychiatr (1984) 0.75
[Long-term study of the incidence of the birth of premature fetuses in Czechoslovakia]. Cesk Gynekol (1983) 0.75
PET/CT significance for planning radiotherapy of head and neck cancer. Neoplasma (2012) 0.75
[How the psychiatrist proceeds in diagnosing mental disorders (results of a single experiment)]. Cesk Psychiatr (1986) 0.75
Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer single-institution outcome analysis. Neoplasma (2012) 0.75
Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy. Neoplasma (2014) 0.75
[Comparison of the effectiveness of three therapeutic programmes in neurotics. II (author's transl)]. Cesk Psychiatr (1981) 0.75
[The effect of the psychotherapist's training and professional practice on his perception of psychotherapeutic interactions]. Cesk Psychiatr (1984) 0.75
The role of registration in a nationwide cancer control program in Slovakia. Arch Geschwulstforsch (1984) 0.75